TPO and autoimmune thrombocytopenic purpura: It should be noted that patients with ITP are likely to be at high risk for thrombosis including being positive for antiphospholipid antibodies [19–22], and treatment with TPO-RAs may further accentuate toward greater thrombogenicity by increasing the risk factors for thrombosis [23].